04 Aug Westin Michigan Avenue Chicago
909 North Michigan Avenue
$209 per night, single or double occupancy
Westin Michigan Avenue Chicago
July 26, 2014
Gregory Holmquist, Pharm.D., BCOP
Pain and Palliative Care Specialist
Dr. Holmquist is on the Board of Advisors of the American Society of Pain Educators. Over the past decade, he has been invited to present over 1,000 CME and CE lectures on pain management across the country. He shares practical and relevant clinical information, with a touch of humor, ensuring that audiences not only listen but also hear an important message on managing pain and making a difference in the lives of their patients.
PILLS, PEOPLE, & PAIN: UNDERSTANDING THE PROBLEM-FINDING THE SOLUTION
ACPE # TBA
1. State three myths and barriers to providing effective use of pharmacological therapies for pain control in patients.
2. State five features of patients that differentiate patients with acute versus chronic pain syndromes.
3. Differentiate addiction, dependence, tolerance, pseudoaddiction, pseudotolerance, and hyperalgesia.
4. Recommend and effectively utilize standard and innovative pharmacological strategies to effectively palliate uncontrolled pain.
5. State the role of selected co-analgesic and adjuvant pain therapies (e.g. antidepressants, anticonvulsants, NSAIDs, topical approaches) in the management of pain.
6. Compare and contrast the pharmacology, pharmacokinetics, side effects and clinical utilization of the commercially available opioid products.
7. Recognize the patient / chronic pain syndrome which can receive the greatest potential benefit from a trial of opioid therapy and be able to implement this therapeutic approach in a manner that minimize the risks of drug diversion, addiction, and side effects.
8. State the common side effects associated with pain medications and be able to recommend strategies to prevent the side effects from impacting the patients’s quality of life.
Dr. William Benefield, Jr, Pharm D., BCPP, FASCP
University of Texas at Austin
William Benefield, Jr, graduated with honors from Auburn University and received his Doctorate of Pharmacy degree from the University of Texas at Austin and the University of Texas Health Science Center at San Antonio. He has been board certified in Psychiatric Pharmacy since 1997 and is a founding member of CPNP. Dr. Benefield is currently a Clinical Assistant Professor of Psychiatry at the University of Texas at Austin where he focuses on developmental disabilities. He has authored and co-authored chapters in Pharmacotherapy, the Pharmacotherapy Case Book, and Applied Therapeutics. He has lectured at national meetings of the ACCP, ASCP, American Epilepsy Society, American Academy of Neurology, and the NCDEU.
Sunday, July 27, 2014
AUTISM AND OTHER PERVASIVE DEVELOPMENTAL DISORDERS
1. Review the clinical presentation of the major psychiatric disorders when presented with coexisting mental retardation.
2. Identify factors that may complicate recognition of a psychiatric disorder in the MR/DD population.
3. Discuss pharmacotherapy to manage the symptoms of the major psychiatric disorders presented in the MR/DD population.
4. Differentiate between the diagnostic criteria for autistic disorder and the other subtypes of pervasive developmental disorders.
5. Discuss the proposed pathophysiology and etiology within the pervasive disorder spectrum.
6. Identify target symptoms associated with pervasive developmental disorders which are responsive to pharmacotherapy.
7. Discuss the role of antipsychotics, antidepressants, mood stabilizers, alpha-adrenergic agonists, opiate agonists, and beta blockers in treating symptoms within the autistic disorder spectrum.
- Chicago - 14 Oct 2022 - 08:00